Integrated Pharmacogenomic/Pharmacokinomic Approach to Optimize GBM Therapy

Grant

Date/time Interval

  • November 1, 2011 - April 30, 2013
  • Total Award Amount

  • 91718.00
  • Direct Costs

  • 91718.00
  • Sponsor Award Id

  • Contributor

  • Christopher Willey M.D., Ph.D.   Investigator  
  • George Gillespie   Investigator  
  • Markus Bredel M.D., Ph.D.   Principal Investigator